AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35470256 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilisation exercise group (SEG)
Number of subjects: 14
Study 35470256 — intervention group
Group type: COMPARATOR
Intervention: Regular exercise group (REG)
Number of subjects: 14
Study 32757879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid ultrasonic advanced bipolar device (HUB)
Number of subjects: 200
Study 32757879 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic coagulating shears
Number of subjects: 200
Study 35359882 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop glucose control (CamAPS FX)
Number of subjects: 38
Study 35359882 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 38
Study 34658160 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 90
Study 34658160 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination Training (CT)
Number of subjects: 90
Study 34658160 — intervention group
Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 90
Study 34658160 — intervention group
Group type: COMPARATOR
Intervention: Stretching Attention Control (AC)
Number of subjects: 90
Study 34788592 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 12
Study 34788592 — intervention group
Group type: COMPARATOR
Intervention: Control manual surgery
Number of subjects: 12
Study 33926665 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery
Number of subjects: 0
Study 33926665 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study 32284995 — intervention group
Group type: EXPERIMENTAL
Intervention: Online education platforms
Number of subjects: 0
Study 32284995 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended instruction modalities
Number of subjects: 0
Study 32284995 — intervention group
Group type: COMPARATOR
Intervention: Traditional in-person instruction
Number of subjects: 0
Study 36136232 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 50 mg
Number of subjects: 846
Study 36136232 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 846
Study 36136232 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 846
Study 36136232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 846
Study 32927091 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 24
Study 32927091 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study 35782699 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual hyperinflation with suction
Number of subjects: 12
Study 35782699 — intervention group
Group type: COMPARATOR
Intervention: Suction alone
Number of subjects: 12
Study 34429172 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment-Based Human Centered Educational Program
Number of subjects: 0
Study 34429172 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 0
Study 32943657 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystoinflation (300 cc saline retro-fill)
Number of subjects: 214
Study 32943657 — intervention group
Group type: COMPARATOR
Intervention: Control (no retro-fill)
Number of subjects: 214
Study 36107462 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 37668
Study 36107462 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment in secondary prevention RCTs
Number of subjects: 37668
Study 33002878 — intervention group
Group type: EXPERIMENTAL
Intervention: ED visits for TBI
Number of subjects: 0
Study 33002878 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital admission rate
Number of subjects: 0
Study 33002878 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission rate by sex
Number of subjects: 0
Study 33002878 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall-related TBI rates
Number of subjects: 0
Study 33002878 — intervention group
Group type: EXPERIMENTAL
Intervention: In-ED mortality
Number of subjects: 0
Study 35142923 — intervention group
Group type: EXPERIMENTAL
Intervention: ER-D (etch-and-rinse with dry dentin)
Number of subjects: 31
Study 35142923 — intervention group
Group type: EXPERIMENTAL
Intervention: ER-M (etch-and-rinse with moist dentin)
Number of subjects: 31
Study 35142923 — intervention group
Group type: EXPERIMENTAL
Intervention: SE-et (self-etch with selective enamel etching)
Number of subjects: 31
Study 35142923 — intervention group
Group type: EXPERIMENTAL
Intervention: SET (self-etch without selective enamel etching)
Number of subjects: 31
Study 34180363 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation combined with vocational rehabilitation
Number of subjects: 37
Study 34180363 — intervention group
Group type: COMPARATOR
Intervention: Vocational rehabilitation only
Number of subjects: 37
Study 32279841 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffold (BVS)
Number of subjects: 341
Study 32279841 — intervention group
Group type: COMPARATOR
Intervention: Everolimus‐eluting stent (EES)
Number of subjects: 341
Study 35895116 — intervention group
Group type: EXPERIMENTAL
Intervention: WiScope® Single use digital flexible ureteroscope
Number of subjects: 242
Study 35895116 — intervention group
Group type: COMPARATOR
Intervention: Reusable flexible ureteroscope
Number of subjects: 242
Study 32985775 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine for 3 months followed by metformin for 9 months (G→Met)
Number of subjects: 91
Study 32985775 — intervention group
Group type: COMPARATOR
Intervention: Metformin alone (Met) for 12 months
Number of subjects: 91
Study 33274381 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone cream (10 mg daily for 10 weeks)
Number of subjects: 48
Study 33274381 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1:1 for 10 weeks)
Number of subjects: 48
Study 32553077 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBOT)
Number of subjects: 120
Study 32553077 — intervention group
Group type: COMPARATOR
Intervention: Medicine only
Number of subjects: 120
Study 36409485 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior foraminotomy
Number of subjects: 265
Study 36409485 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy with fusion
Number of subjects: 265
Study 34459659 — intervention group
Group type: EXPERIMENTAL
Intervention: Amulet occluder
Number of subjects: 1878
Study 34459659 — intervention group
Group type: COMPARATOR
Intervention: Watchman device
Number of subjects: 1878
Study 32960179 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous cervical vagus nerve stimulation (tcVNS)
Number of subjects: 24
Study 33804207 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical platform training
Number of subjects: 60
Study 33804207 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational platform training
Number of subjects: 60
Study 33804207 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 60
Study 33214190 — intervention group
Group type: COMPARATOR
Intervention: Rapid-acting insulin (RAI)
Number of subjects: 136
Study 33214190 — intervention group
Group type: EXPERIMENTAL
Intervention: Human regular insulin (HRI)
Number of subjects: 136
Study 33729214 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rehabilitation (initiated on postoperative day 1 with removal of the extension splint for quadriceps activation and ROM exercises)
Number of subjects: 36
Study 33729214 — intervention group
Group type: COMPARATOR
Intervention: Late rehabilitation (full-time immobilization in an extension splint for 3 weeks)
Number of subjects: 36
Study 33729214 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rehabilitation
Number of subjects: 36
Study 33729214 — intervention group
Group type: COMPARATOR
Intervention: Late rehabilitation
Number of subjects: 36
Study 32965493 — intervention group
Group type: EXPERIMENTAL
Intervention: Early endovenous ablation with compression therapy within 2 weeks of randomization (n = 224)
Number of subjects: 450
Study 32965493 — intervention group
Group type: COMPARATOR
Intervention: Deferred endovenous treatment with compression therapy (n = 226)
Number of subjects: 450
Study 35152577 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (2 Hz/10 Hz frequency, once every other day, 3 times a week for 4 weeks)
Number of subjects: 60
Study 35152577 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 60
Study 35152577 — intervention group
Group type: COMPARATOR
Intervention: Caltrate (2 pills a day for 4 weeks)
Number of subjects: 60
Study 34029565 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patch treatment (21 mg daily)
Number of subjects: 50
Study 34029565 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch use
Number of subjects: 50
Study 35105591 — intervention group
Group type: EXPERIMENTAL
Intervention: Melodies for Mums (M4M)
Number of subjects: 560
Study 35105591 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance for Parkinson's (PD-Ballet)
Number of subjects: 560
Study 35105591 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 560
Study 32671846 — intervention group
Group type: EXPERIMENTAL
Intervention: Lialda 2 × 1.2 g once daily (QD)
Number of subjects: 37
Study 32671846 — intervention group
Group type: EXPERIMENTAL
Intervention: Asacol 6 × 400 mg QD
Number of subjects: 37
Study 32671846 — intervention group
Group type: EXPERIMENTAL
Intervention: Asacol 2 × 400 mg three times daily (TID)
Number of subjects: 37
Study 35726292 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway nursing combined with humanized nursing
Number of subjects: 100
Study 35726292 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control group)
Number of subjects: 100
Study 33183968 — intervention group
Group type: EXPERIMENTAL
Intervention: Top tertile of MIND diet score
Number of subjects: 350
Study 33183968 — intervention group
Group type: EXPERIMENTAL
Intervention: Greatest MIND diet scores
Number of subjects: 350
Study 33183968 — intervention group
Group type: EXPERIMENTAL
Intervention: Greatest adherence to MIND diet (postmenopausal women)
Number of subjects: 350
Study 33183968 — intervention group
Group type: EXPERIMENTAL
Intervention: Greatest adherence to MIND diet (normal-weight women)
Number of subjects: 350
Study 32221405 — intervention group
Group type: EXPERIMENTAL
Intervention: Education below GCSE O-levels
Number of subjects: 1864
Study 32221405 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco smoking
Number of subjects: 1864
Study 32221405 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug use (especially injectable drugs)
Number of subjects: 1864
Study 32221405 — intervention group
Group type: EXPERIMENTAL
Intervention: Homelessness
Number of subjects: 1864
Study 32221405 — intervention group
Group type: EXPERIMENTAL
Intervention: Area-level deprivation
Number of subjects: 1864
Study 32221405 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco use
Number of subjects: 1864
Study 32221405 — intervention group
Group type: EXPERIMENTAL
Intervention: Class-A drug use
Number of subjects: 1864
Study 36064596 — intervention group
Group type: EXPERIMENTAL
Intervention: 28-day multidisciplinary programme
Number of subjects: 440
Study 36064596 — intervention group
Group type: COMPARATOR
Intervention: Standard ambulatory care
Number of subjects: 440
Study 33565742 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofacilitation (three types of physical therapy: Motor Program Activating Therapy, Vojta's reflex locomotion, Functional Electric Stimulation in Posturally Corrected Position)
Number of subjects: 92
Study 33565742 — intervention group
Group type: EXPERIMENTAL
Intervention: Vojta's reflex locomotion
Number of subjects: 92
Study 33565742 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofacilitation (irrespective type of therapy)
Number of subjects: 92
Study 36306497 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative therapies (such as surgery or radiation)
Number of subjects: 0
Study 36306497 — intervention group
Group type: EXPERIMENTAL
Intervention: Metastasis-directed therapy
Number of subjects: 0
Study 36306497 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing phase III studies
Number of subjects: 0
Study 32535780 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR algorithm using diagnosis codes for NASH cirrhosis
Number of subjects: 5415
Study 32327014 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held device (HHD)
Number of subjects: 36
Study 32327014 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-worn device (WWD) with backlight on
Number of subjects: 36
Study 32327014 — intervention group
Group type: COMPARATOR
Intervention: Standardized laptop (L)
Number of subjects: 36
Study 35604087 — intervention group
Group type: EXPERIMENTAL
Intervention: MARCI technique
Number of subjects: 20
Study 35604087 — intervention group
Group type: COMPARATOR
Intervention: LP technique
Number of subjects: 20
Study 33822067 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcr‐Abl TKIs use during the previous 90 days
Number of subjects: 66702
Study 33822067 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcr‐Abl TKIs use during the previous 365 days
Number of subjects: 66702
Study 33822067 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcr‐Abl TKIs use during the previous 60 days (women)
Number of subjects: 66702
Study 33822067 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcr‐Abl TKIs use during the previous 60 days (men)
Number of subjects: 66702
Study 37156658 — intervention group
Group type: EXPERIMENTAL
Intervention: MiSight® 1 day (omafilcon A, CooperVision, Inc.)
Number of subjects: 135
Study 37156658 — intervention group
Group type: COMPARATOR
Intervention: Single-vision control (Proclear® 1 day, omafilcon A, CooperVision, Inc.)
Number of subjects: 135
Study 33184754 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (80 mg/m2) on day 1 plus Gemcitabine (1000 mg/m2) on days 1 and 8 every 3 weeks
Number of subjects: 71
Study 33184754 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC: 6 mg/mL/min) on day 1 plus Nab-paclitaxel (75 mg/m2) on days 1, 8, and 15 every 3 weeks
Number of subjects: 71
Study 33184754 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin + Gemcitabine (CG)
Number of subjects: 71
Study 33184754 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin + Nab-paclitaxel (CnP)
Number of subjects: 71
Study 34391956 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Number of subjects: 818
Study 32217847 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative exploration of recovery perceptions from chronic whiplash patients and physiotherapists
Number of subjects: 20
Study 32217847 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapists' beliefs on recovery
Number of subjects: 20
Study 32217847 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers and facilitators to recovery
Number of subjects: 20
Study 34801133 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic clip closure
Number of subjects: 231
Study 34801133 — intervention group
Group type: COMPARATOR
Intervention: Control (no clip)
Number of subjects: 231
Study 34049349 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoDrop
Number of subjects: 39
Study 34049349 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoSqueeze
Number of subjects: 39
Study 34049349 — intervention group
Group type: EXPERIMENTAL
Intervention: SimplyTouch
Number of subjects: 39
Study 34049349 — intervention group
Group type: COMPARATOR
Intervention: No drop aid (Control)
Number of subjects: 39
Study 32873667 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg per day
Number of subjects: 300
Study 32873667 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 30 mg per day
Number of subjects: 300
Study 34265044 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors/ARBs
Number of subjects: 64
Study 34265044 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine ± carvedilol
Number of subjects: 64
Study 32563960 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative magnetic resonance imaging (MRI)
Number of subjects: 360
Study 32563960 — intervention group
Group type: COMPARATOR
Intervention: No preoperative magnetic resonance imaging (No MRI)
Number of subjects: 360
Study 35505199 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP with combined air polishing (erythritol/chlorhexidine powder) and Nd:YAG laser (2 W, 200 mJ/pulse, 10 Hz) therapy
Number of subjects: 24
Study 35505199 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 24
Study 34407481 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth dyadic teamwork intervention
Number of subjects: 29
Study 34407481 — intervention group
Group type: COMPARATOR
Intervention: Attention control condition
Number of subjects: 29
Study 35524961 — intervention group
Group type: EXPERIMENTAL
Intervention: KBAM (200 mg ketamine, 109.2 mg butorphanol, 36.4 mg azaperone, 43.6 mg medetomidine)
Number of subjects: 10
Study 35524961 — intervention group
Group type: COMPARATOR
Intervention: DEA (40 mg detomidine premedication, followed 20 minutes later by 3.9 to 4.4 mg etorphine and 16 to 18 mg acepromazine)
Number of subjects: 10
Study 34536218 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily
Number of subjects: 109
Study 35956202 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine/Propofol (esketamine: 0.2 mg/kg)
Number of subjects: 66
Study 35956202 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil/Propofol (sufentanil: 0.2 μg/kg)
Number of subjects: 66
Study 36156732 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation program using RehaCom software and paper-pencil language training
Number of subjects: 30
Study 36156732 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation program
Number of subjects: 30
Study 36156732 — intervention group
Group type: COMPARATOR
Intervention: Control Group (standard clinical care)
Number of subjects: 30
Study 33495596 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk score in carriers of HCM-causing rare variants
Number of subjects: 19514
Study 33495596 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased left ventricular (LV) contractility
Number of subjects: 19514
Study 33495596 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic correlations between LV traits and cardiomyopathies
Number of subjects: 19514
Study 33495596 — intervention group
Group type: EXPERIMENTAL
Intervention: Genome-wide association studies
Number of subjects: 19514
Study 35533230 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium perborate
Number of subjects: 20
Study 35533230 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion
Number of subjects: 20
Study 35533230 — intervention group
Group type: COMPARATOR
Intervention: Etch bleach seal
Number of subjects: 20
Study 35533230 — intervention group
Group type: COMPARATOR
Intervention: In-office bleaching with 30% H2O2
Number of subjects: 20
Study 33022421 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid photodynamic therapy (5ALA-PDT)
Number of subjects: 51
Study 35945412 — intervention group
Group type: COMPARATOR
Intervention: Fresnel press-on prism (FPP)
Number of subjects: 101
Study 35945412 — intervention group
Group type: EXPERIMENTAL
Intervention: Binocular vision training (BVT) combined with Fresnel press-on prism (FPP)
Number of subjects: 101
Study 33409700 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasted and acid-etched miniscrews
Number of subjects: 31
Study 33409700 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-sandblasted and non-acid-etched miniscrews)
Number of subjects: 31
Study 33302661 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL 0.375% ropivacaine
Number of subjects: 103
Study 33302661 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL 0.375% ropivacaine
Number of subjects: 103
Study 36085580 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing counter without an algorithm (Group B)
Number of subjects: 235
Study 36085580 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing counter with a masticatory behavior change algorithm (Group C)
Number of subjects: 235
Study 36085580 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 235
Study 33400845 — intervention group
Group type: EXPERIMENTAL
Intervention: Savolitinib 600 mg
Number of subjects: 45
Study 33400845 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 45
Study 33400845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 32736046 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal herbal oil (containing violet oil, saffron oil, and lettuce seeds oil)
Number of subjects: 50
Study 32736046 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sesame oil)
Number of subjects: 50
Study 35776001 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Care Intervention (ICI)
Number of subjects: 456
Study 35776001 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 456
Study 34875716 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet during TKA
Number of subjects: 120
Study 34875716 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet during TKA
Number of subjects: 120
Study 34337913 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-IL-6R therapy (Tocilizumab and Sarilumab)
Number of subjects: 105
Study 34337913 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anti-IL-6R therapy)
Number of subjects: 105
Study 32119803 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-restricted diet (10% CHO, 50% fat, 40% protein) rich in plant foods and mushrooms
Number of subjects: 17
Study 32119803 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO-restricted diet (10% CHO, 60% fat, 30% protein) with more animal foods
Number of subjects: 17
Study 32119803 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (61% CHO, 21% fat, 18% protein)
Number of subjects: 17
Study 32119803 — intervention group
Group type: EXPERIMENTAL
Intervention: All trials (CHO-restricted and LF)
Number of subjects: 17
Study 32119803 — intervention group
Group type: EXPERIMENTAL
Intervention: All trials
Number of subjects: 17
Study 32119803 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 17
Study 36474395 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin with strengthening exercises
Number of subjects: 90